Endobronchial Small Cell Lung Cancer Masquerading as Carcinoid Tumour in a Young Female: A Case Report

Abstract

Bronchial Carcinoid Tumours also known as BCTs, are remarkable neuroendocrine malignancies that can denature chemical compounds with biological activity. Bronchial carcinoid tumours are also known as BCTs. The phrase “bronchial adenomas” was once used to refer to BCTs; however, this nomenclature is no longer utilised because BCTs are neither glandular nor invariably benign. Instead, the term “Bronchial Cystic Tumours” is used to refer to BCTs in this context (BCTs). They are normally a neoplasm that expands slowly and displays a variety of behaviours, yet, they are also capable of expanding rapidly and being significantly more aggressive in general. Despite the fact that smoking is a significant risk factor for Small Cell Lung Cancer (SCLC), which is a more severe form of lung cancer than carcinoid. In addition, surgery is still the treatment of choice for carcinoid tumours, although chemoradiation and chemotherapy are the only options for patients with stage four SCLC. Here the authors discuss the case of 30 years old young female patient, who was erroneously diagnosed with endobronchial carcinoid turned out to be a SCLC. Because of the significant connection between smoking and SCLC, malignancies are not usually seen in young females. The relevant patient’s investigations were consistent with a small cell carcinoma of the lung. Immunohistochemistry for CD56 and synaptophysin turned out to be positive. The patient received six cycles of chemotherapy with an injection of Cisplatin and an injection of Etoposide three weekly. She was followed-up after three months and did have symptomatic relief.